Kutsch N, Giza A, Robrecht S, Stumpf J, et al. Fludarabine, cyclophosphamide, and rituximab as first-line treatment in patients with chronic lymphocytic leukemia: A long-term analysis of the German CLL Study Group (GCLLSG) registry. Eur J Haematol 2024 May 1. doi: 10.1111/ejh.14220.
PMID: 38693677